| Name | 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine |
|---|---|
| Synonyms |
2-Methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Pyridine, 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 355.5±42.0 °C at 760 mmHg |
| Molecular Formula | C13H20BNO3 |
| Molecular Weight | 249.114 |
| Flash Point | 168.8±27.9 °C |
| Exact Mass | 249.153625 |
| PSA | 40.58000 |
| LogP | 1.69780 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.490 |
| Hazard Codes | T+ |
|---|---|
| HS Code | 2934999090 |
|
~65%
1083168-84-6 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2008/141119 A2, 2008 ; Location in patent: Page/Page column 96 ; WO 2008/141119 A2 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |